Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rexall Health Solutions is a healthcare services business operating under the Rexall pharmacy organization in Canada. It appears to function as a commercial pharmacy and care-solutions division focused on specialized clinical care, medication management, long-term care, transitional care, mail-order pharmacy support, infusion-related services, and home health offerings rather than as a drug-development biotech company. The business is associated with Rexall Pharmacy Group, a major Canadian pharmacy chain with roughly 400 locations and approximately 8,000 employees. Rexall was previously owned by McKesson and was sold to Birch Hill Equity Partners in a transaction that closed on December 30, 2024. For a biotech analyst, this entity is best understood as a healthcare delivery and pharmacy-services organization, not a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rexall Health Solutions.